Autologous hematopoietic stem cell transplant at experienced centers in the current era can include indefinite disease ...
A new study identified protein targets and drug candidates, including opportunities to repurpose existing drugs. Six key ...
FDA clearance allows Imviva to test CTA313, an off-the-shelf CAR T-cell therapy, in progressive MS and other autoimmune ...
Using the approved multiple sclerosis therapy Kesimpta helps keep relapsing MS stable over time for most adults, a real-world ...
Scientists are testing two new molecules that may repair myelin in MS, shifting the focus from slowing attacks to true nerve ...
NEW YORK, NY, UNITED STATES, March 24, 2026 /EINPresswire.com/ — Scientists at the Tisch Multiple Sclerosis Research Center of New York (MSRCNY) have identified a ...
TGTX’s early-stage study showed the injectable form of BRIUMVI delivered quick and meaningful symptom relief in most ...
ScienceAlert on MSN
World MS Day: Immune cell discovery might explain multiple sclerosis at its worst
A cross-section of the spinal cord showing neurons and glial cells. (Juan Carlos Juarez Jaramillo/iStock/Getty Images Plus) A ...
A new study has revealed a group of blood proteins that are altered in people who go on to develop multiple sclerosis (MS), in some cases more than a decade before diagnosis. The findings offer hope ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results